Nuevolution brings in prominent board member
Danish biotech Nuevolution has secured the co-founder and current chief researcher of a US-based biotech for its board of directors.
by Benjamin Werner Christensen
Danish company Nuevolution has brought fresh competencies into its board of directors in the form of Brian Zambrowicz, who is co-founder and current chief scientific officer in the public, US-based biotech Lexicon Pharmaceuticals.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Nuevolution strikes deal with Swiss pharma giant
For abonnenter
